Login
Navigate Fool.com
Will NLNK beat
the market?
Community Rating: 1 Star: Ominous

19.55 0.23 (1.19%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $19.37
Previous Close $19.32
Daily Range $18.28 - $20.25
52-Week Range $11.19 - $53.48
Market Cap $544.7M
P/E Ratio -16.24
Dividend (Yield) $0.00 (0.0%)
Volume 450,910
Average Daily Volume 721,978
Current FY EPS -$1.80

How do you think NLNK
will perform against the market?

Top NLNK Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

3 Biggest Biotech Crashes in March

Here's why Celldex (CLDX), Acceleron (XLRN), and Newlink (NLNK) all tumbled in March.

3 Biotechs Bucking the Downtrend

Three biotech winners amid a sea of losers.

This Week in Biotech: Put It in Print

Four clinical updates -- two of them in print -- as well as an FDA approval after seven years are this week's top biotech stories.

Why Alpha Natural Resources, NewLink Genetics, and Furmanite Tumbled Today

Although the broader stock market just barely managed to hit a new all-time record, several stocks fell sharply on company-specific news. Find out why these three stocks fell today.

Friday's ETF with Unusual Volume: IBB

Why NewLink Genetics Corp. Shares Plunged

NewLink Genetics shares dip after it provides an update on its phase 3 study of algenpantucel-L in pancreatic cancer.

US Stocks Gain On Increased Payrolls in February; Foot Locker up on Q4 Beat

Morning Movers in Biotech: Gilead Sciences, NewLink Genetics Corp. and Novartis AG

Today's top stories in biotech and health care.

Why NewLink Genetics Corp. Shares Swooned

NewLink Genetics shares dip following a downgrade. Find out what you should really be doing following this analyst action.

5 States Where Pancreatic Cancer Prevalence Is the Highest

Pancreatic cancer has the lowest five-year survival rate and is the most prevalent in these five states. Here are the existing and developing therapies you need to have your eyes on.

See More NLNK News...

Sector

Healthcare

Industry

Drugs

NewLink Genetics Corporation (NLNK) Description

NewLink Genetics Corporation is a biopharmaceutical company focused on discovering developing and commercializing novel immunotherapeutic products to improve cancer treatment options for patients and physicians. Website: http://www.linkp.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks